Fortis Healthcare
add_icon

Fortis Healthcare

965.80
-4.55
(-0.47%)
Market Cap
72,913.86 Cr
PE Ratio
73.94
Volume
2,92,797.00
Day High - Low
974.55 - 960.00
52W High-Low
1,104.30 - 698.70
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
72,913.86 Cr
EPS
13.80
PE Ratio
73.94
PB Ratio
7.77
Book Value
122.24
EBITDA
2,062.74
Dividend Yield
0.10 %
Sector
Hospitals
Return on Equity
8.83
Debt to Equity
0.22
Analyst Rating and Forecast
- By Refinitiv from16 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+75.00 %
+75.00 %
Hold
Hold+18.75 %
+18.75 %
Sell
Sell+6.25 %
+6.25 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Fortis Healthcare Limited has released the audio recording of its Q4FY26 and FY26 earnings call held on May 25, 2026. The recording covers audited standalone and consolidated financial results.
positive
Fortis Healthcare Plans to Add 2,000 Beds in 3 Years23 hrs ago
Fortis Healthcare plans to expand capacity by adding 2,000 beds over the next three years, with 500 beds expected to become available in 2027.
positive
Fortis Healthcare reported a consolidated net profit of ₹1,064.19 crore for FY26, up from ₹809.38 crore in the previous year. The board recommended a final dividend of ₹1 per share.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
8,342.00
#1 1,19,945.16
60.02
#1 25,228.50
14.70
#1 2,032
33.00
73.21
996.30
96,953.44
69.05
8,373.45
16.56
1,464
7.27
44.00
965.80
#3 72,913.86
#7 73.94
#2 9,127.84
#7 16.28
#3 1,064
#3 44.26
61.20
755.15
39,125.91
91.78
4,643.22
8.32
384
#1 79.65
58.59
1,914.20
39,118.75
48.63
7,896.04
#1 41.63
788
13.53
62.30
1,245.00
33,464.40
60.09
4,410.27
16.94
584
39.64
67.84
762.25
30,500.59
126.29
3,904.60
27.31
198
-68.80
59.04
477.60
15,130.73
90.43
2,080.08
18.39
168
17.65
65.24
1,376.80
13,982.66
52.98
1,703.08
8.69
262
38.41
65.06
277.41
11,982.19
#1 40.99
1,679.36
17.77
272
46.56
75.36

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
16.28 %
Net Income Growth
31.48 %
Cash Flow Change
29.44 %
ROE
17.11 %
ROCE
0.92 %
EBITDA Margin (Avg.)
6.40 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
1,085
1,152
1,150
1,024
1,106
1,176
1,257
1,630
1,164
1,229
1,258
1,175
1,108
1,081
1,156
1,164
1,528
1,170
1,277
1,178
1,133
614
1,029
1,205
1,278
1,733
1,475
1,487
1,391
1,519
1,682
1,586
1,669
1,667
1,788
1,699
1,803
1,873
2,006
1,975
2,032
2,198
2,381
2,277
2,375
Expenses
1,022
986
1,087
1,066
1,091
1,059
1,097
1,023
1,045
1,071
1,138
1,069
1,907
1,034
1,172
1,193
1,069
996
1,028
1,012
987
709
875
987
1,055
1,135
1,178
1,180
1,157
1,237
1,304
1,283
1,372
1,386
1,440
1,396
1,405
1,516
1,613
1,553
1,625
1,676
1,775
1,805
1,845
EBITDA
62
166
62
-42
15
118
160
607
118
158
120
106
-799
47
-16
-29
459
174
250
166
146
-96
155
218
223
598
297
307
234
282
378
302
297
282
349
303
398
356
393
422
406
522
606
472
530
Operating Profit %
3 %
4 %
-2 %
-5 %
-2 %
6 %
8 %
10 %
7 %
7 %
5 %
5 %
-76 %
1 %
-3 %
-8 %
10 %
13 %
15 %
13 %
11 %
-17 %
12 %
16 %
16 %
20 %
19 %
20 %
16 %
17 %
19 %
18 %
16 %
16 %
19 %
17 %
21 %
18 %
19 %
19 %
19 %
23 %
24 %
20 %
22 %
Depreciation
61
53
0
0
72
48
52
60
63
59
61
59
60
57
56
60
60
71
71
70
80
72
74
73
72
73
75
76
77
74
77
83
82
79
84
87
92
91
95
97
102
102
106
120
122
Interest
37
34
30
32
38
42
46
75
67
64
66
63
64
76
85
111
65
51
49
48
57
41
42
42
41
38
40
38
30
31
33
33
32
32
32
33
35
35
36
45
68
70
75
86
84
Profit Before Tax
-22
88
44
-58
-96
28
62
472
-11
35
-7
-17
-924
-87
-157
-201
334
52
130
48
9
-208
38
103
110
486
182
193
126
176
268
186
183
171
233
183
271
230
261
279
237
351
425
266
324
Tax
-10
-9
-17
-29
-8
3
24
19
26
12
17
3
-9
-34
-15
-20
183
-26
6
118
50
-20
23
49
48
56
51
51
39
42
50
44
45
47
49
49
68
56
68
25
49
84
97
68
53
Net Profit
-12
97
61
-29
-88
25
38
453
-38
23
-24
-19
-914
-53
-142
-180
151
78
124
-69
-41
-188
16
54
62
431
131
142
87
134
218
142
138
124
184
134
203
174
193
254
188
267
329
197
271
EPS in ₹
-0.38
2.01
1.19
-0.65
-1.91
0.35
0.68
9.49
-0.79
0.10
-0.88
-0.71
-17.97
-1.36
-3.21
-3.06
1.80
0.90
1.47
-1.01
-0.59
-2.37
-0.05
0.40
0.57
3.49
1.42
1.55
0.90
1.62
2.71
1.72
1.76
1.48
2.30
1.78
2.37
2.20
2.34
3.28
2.44
3.45
4.26
2.57
3.52

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
15,966
Fixed Assets
4,218
3,776
5,419
4,992
8,477
8,802
8,799
9,416
9,426
9,874
10,424
7,943
Current Assets
1,636
1,434
1,775
1,282
1,667
941
1,037
1,133
1,406
1,421
1,471
1,819
Capital Work in Progress
228
201
268
226
450
204
165
194
228
542
407
432
Investments
616
1,449
1,878
1,732
270
175
186
104
210
230
169
135
Other Assets
2,554
1,807
2,152
1,672
2,755
2,167
2,005
2,172
2,569
2,643
2,692
0
Total Equity & Liabilities
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
15,966
Current Liabilities
1,602
1,476
1,927
2,134
3,591
2,579
1,233
1,269
1,426
3,170
1,607
2,115
Non Current Liabilities
1,813
1,616
1,480
1,171
1,248
1,563
3,204
3,607
2,907
1,563
2,915
3,683
Total Equity
4,201
4,140
6,311
5,317
7,113
7,206
6,718
7,008
8,100
8,556
9,169
9,896
Reserve & Surplus
3,585
3,534
4,626
3,543
5,846
5,906
5,365
5,423
6,487
6,908
8,162
9,141
Share Capital
463
463
518
519
755
755
755
755
755
755
755
755

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-66
-38
225
-513
799
-627
212
-153
-22
125
-70
Investing Activities
213
122
-1,001
-333
-3,279
64
-131
-501
-373
-889
-780
Operating Activities
24
195
967
493
-179
172
486
865
822
1,100
1,424
Financing Activities
-304
-354
259
-672
4,257
-862
-143
-517
-471
-87
-714

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
26.32 %
0.00 %
23.24 %
23.31 %
25.26 %
26.77 %
27.40 %
27.17 %
27.90 %
27.84 %
25.97 %
DIIs
13.44 %
15.20 %
15.66 %
15.50 %
16.72 %
17.44 %
19.94 %
20.38 %
20.70 %
22.16 %
26.55 %
29.35 %
31.15 %
32.31 %
30.73 %
30.05 %
29.46 %
29.79 %
29.14 %
29.33 %
31.35 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.96 %
15.16 %
15.98 %
14.89 %
13.96 %
13.58 %
12.92 %
12.39 %
12.05 %
11.80 %
11.13 %
11.04 %
10.82 %
10.47 %
10.36 %
10.21 %
10.22 %
10.17 %
10.14 %
10.14 %
9.96 %
Others
41.43 %
38.47 %
37.20 %
38.44 %
38.15 %
37.82 %
35.98 %
36.06 %
36.08 %
34.86 %
4.83 %
28.44 %
3.63 %
2.75 %
2.48 %
1.81 %
1.75 %
1.70 %
1.65 %
1.53 %
1.54 %
No of Share Holders
0
1,09,889
1,44,634
1,66,743
1,54,572
1,56,881
1,60,762
1,58,455
1,37,894
1,35,047
1,31,516
1,35,664
1,57,165
1,54,260
2,04,184
2,21,750
2,18,329
2,05,373
2,20,766
2,33,156
2,26,685

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 1 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.14 0.13 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
20 Jul 2023 DIVIDEND Dividend
1.00 /share
20 Jul 2023 289.05 328.75
24 Jul 2024 DIVIDEND Dividend
1.00 /share
24 Jul 2024 469.50 487.45
02 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
02 Aug 2024 471.55 505.05
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 601.65 623.10
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 581.00 651.05
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 682.75 685.85
25 Jul 2025 DIVIDEND Dividend
1.00 /share
25 Jul 2025 685.85 846.55
06 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Aug 2025 850.05 867.90
11 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Aug 2025 773.45 897.45
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 1,030.70 992.70
13 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Feb 2026 857.30 928.55
22 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 May 2026 970.70 967.30

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome14 hrs ago
Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
CSR Policy3 days ago
Compliances-Half Yearly Communication - Debt Instruments 3 days ago
Cost Auditor Appointment3 days ago
Announcement under Regulation 30 (LODR)-Change in Management3 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation3 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release3 days ago
Corporate Action-Board approves Dividend3 days ago
Announcement under Regulation 30 (LODR)-Dividend Updates3 days ago
Financial Results For The Quarter And Year Ended March 31 20263 days ago
Board Meeting Outcome for Approval Of Financial Results For The Quarter And Year Ended March 31 2026 And Recommendation Of Final Dividend For The Year Ended March 31 20263 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) And Recommendation Of Final Dividend10 days ago
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) Regarding A Material Litigation Filed By Northern TK Venture Pte Ltd. (NTK) The Promoter Shareholder Of The Company Against Apr 29, 2026
Intimation Of Grant Of Employee Stock Options (Options) Under Fortis Healthcare Limited Employee Stock Option Scheme 2026."Apr 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 22, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 22, 2026
Disclosure Under Chapter XIV - Centralized Database For Corporate Bonds/ Debentures Of SEBI Master Circular Dated October 15 2025.Apr 10, 2026
Compliances-Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017) Apr 08, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)- Income Tax Order For Wholly Owned SubsidiaryApr 01, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)- Income Tax Order For Wholly Owned SubsidiaryMar 28, 2026
Closure of Trading WindowMar 25, 2026
Approval Of Employee Stock Option Scheme 2026 By Shareholders.Mar 18, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 18, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 18, 2026
Special Window For Re-Lodgement Of Transfer Requests Of Physical SharesMar 16, 2026
Effective Date Of Scheme Of Arrangement- Merger By AbsorptionMar 02, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) Regarding A Material Litigation Filed By Northern TK Venture Pte Ltd. (NTK) The Promoter Shareholder Of The Company Against Feb 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements Regulations 2015- Notice Of Postal BallotFeb 16, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 16, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2026
Revision In Related Party Transaction PolicyFeb 13, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 13, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 13, 2026
Outcome Of The Board Meeting-13-02-2026Feb 13, 2026
Board Meeting Outcome for Outcome Of The Board Meeting-13-02-2026Feb 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Board Meeting Intimation for Board Meeting Intimation For Prior Intimation Of Board Meeting Under Regulation 29 And 50 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 06, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 23, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 23, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 22, 2026
Announcement Regarding Scheme Of Merger By Absorption Between Wholly Owned SubsidiariesJan 16, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJan 16, 2026
Update On Acquisition Of TMI Healthcare Private LimitedJan 09, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 08, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Active Momentum Fund Direct-Growth
2.08%
96254
0.50%
2.08%
ICICI Prudential Quality Fund Direct-Growth
1.20%
82916
0.41%
1.20%
Helios Small Cap Fund Direct-Growth
0.49%
50000
0.49%
0.49%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
4.35%
50000
1.26%
-0.24%
TRUSTMF Mid Cap Fund Direct-Growth
2.37%
26145
1.08%
2.37%
LIC MF Consumption Fund Direct-Growth
0.98%
-25623
-0.40%
-0.49%
TRUSTMF Multi Cap Fund Direct-Growth
0.98%
14604
0.26%
0.98%
SBI Nifty200 Momentum 30 Index Fund Direct-Growth
2.20%
3183
0.09%
0.04%
Tata Nifty Midcap 150 Index Fund Direct-Growth
1.24%
2909
0.04%
-0.06%
Groww Arbitrage Fund Direct-Growth
0.53%
2325
0.53%
0.53%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.44%
2004
0.44%
0.44%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
1.23%
-1398
0.04%
-0.07%
JioBlackRock Sector Rotation Fund Direct-Growth
0.31%
1162
0.07%
0.03%
Aditya Birla Sun Life BSE 500 Momentum 50 Index Fund Direct-Growth
1.85%
1139
0.14%
-0.22%
DSP Nifty Healthcare Index Fund Direct-Growth
4.76%
788
0.47%
-0.13%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.86%
759
0.06%
-0.01%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.46%
742
0.46%
0.46%
Kotak Nifty500 Momentum 50 Index Fund Direct-Growth
1.78%
541
0.07%
0.00%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.62%
531
0.62%
0.62%
Kotak Nifty Alpha 50 Index Fund Direct-Growth
1.56%
501
0.03%
-0.25%
Kotak Nifty Midcap 150 Index Fund Direct-Growth
1.24%
434
0.05%
-0.06%
DSP Nifty Midcap 150 Index Fund Direct-Growth
1.23%
184
0.05%
-0.06%
Groww Nifty Midcap 150 Index Fund Direct-Growth
1.23%
69
0.03%
-0.07%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.24%
58
0.01%
0.00%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.81%
39
0.03%
-0.05%

Technical Indicators

RSI(14)
Neutral
61.20
ATR(14)
Less Volatile
24.68
STOCH(9,6)
Neutral
50.17
STOCH RSI(14)
Oversold
12.02
MACD(12,26)
Bearish
-2.45
ADX(14)
Strong Trend
25.44
UO(9)
Bearish
46.22
ROC(12)
Uptrend And Accelerating
2.39
WillR(14)
Neutral
-43.23

About Fortis Healthcare

Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child...more
Listing Date
09 May, 2007(19 Years, 17 days)
Chairperson NameLeo Puri